Thursday, January 14, 2021

January 14, 2021 at 09:34PM Potential Risk of Variant Creutzfeldt-Jakob Disease (vCJD) From Plasma-Derived Products

In recent years, questions have been raised concerning the potential risk of variant Creutzfeldt-Jakob disease (vCJD - a rare but fatal brain infection) for recipients of plasma- derived clotting factors.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3oK9rDP

No comments:

Post a Comment